Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$3.92 USD
-0.07 (-1.75%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $3.91 -0.01 (-0.26%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
SRTS 3.92 -0.07(-1.75%)
Will SRTS be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for SRTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SRTS
Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?
New Strong Buy Stocks for February 12th
SRTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline
Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
Other News for SRTS
Navigating Uncertainty: How Global Crises Threaten Sensus Healthcare’s Growth and Operations
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
Sensus Healthcare launches 'Fair Deal Agreement' for SRT-100 Vision
3 Stocks to Buy That Are Up 100% or More in 2024